Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

Overview | Financials
Company Name Collegium Pharmaceutical, Inc.
Symbol COLL
Currency USD
Price 33.46
Market Cap 1,077,873,748
Dividend Yield 0%
52-week-range 21.4 - 42.287
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Joseph J. Ciaffoni
Website https://www.collegiumpharma.com

An error occurred while fetching data.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to

Related Stocks

BioLife Solutions, Inc. logo

BioLife Solutions, Inc.

BLFS

24.07 USD

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

37.63 USD

Bioventus Inc. logo

Bioventus Inc.

BVS

13.58 USD

Humacyte, Inc. logo

Humacyte, Inc.

HUMA

5.39 USD

Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX

16.96 USD

Quantum-Si incorporated logo

Quantum-Si incorporated

QSI

0.768 USD

Financials

Numbers are in millions USD

Numbers are in millions USD